The host genetic background has been considered one of the factors that influence leprosy outcome, a chronic infectious disease caused by Mycobacterium leprae. Genome scans demonstrated that the 6p21 region is associated with leprosy and a substantial number of population-based studies analyzing human leukocyte antigen (HLA) class II loci suggested association of HLA-DR with leprosy. However, some studies lacked robustness as they had limited power. Indeed, experimental designs require increased sample size to achieve adequate power, as well as replication studies with independent samples for confirmation of previous findings. In this work, we analyzed the influence of the HLA-DRB1 locus on leprosy susceptibility per se and disease type using a case-control design carried out in Brazilians (578 cases and 691 controls) and a replication study based on a family design in a Vietnamese population (n ¼ 194 families). The results showed that HLA-DRB1*10 is associated with susceptibility to leprosy and HLA-DRB1*04 is associated with resistance, both in the Brazilian and Vietnamese populations suggesting that these alleles play an important role in the activation of cellular immune responses against M. leprae.
Introduction
Leprosy is a human infectious disease caused by the obligate intracellular pathogen, Mycobacterium leprae, which colonizes macrophages in skin and Schwann cells in peripheral nerves. Although the number of registered cases decreased in the past 20 years worldwide, leprosy still affects about 400000 individuals that are newly diagnosed each year. However, epidemiological data have shown that only a small percentage of people exposed to the bacillus develop the disease, suggesting that the majority of individuals are resistant, mounting effective cellular immune responses. 1 The clinical spectrum of leprosy includes two polar and three borderline forms classified according to clinical, histological and immunological features. 2 Indeed, the leprosy spectrum is classically used as a paradigm of immunological response. The activation of cellular immune responses characterized by the interferon gamma (IFNg)/interleukin (IL)-12/23 axis is considered protective of leprosy per se.
3 Some patients are able to mount a cellular immunity that restrains replication of the bacilli and spread of the disease without hampering disease progression. These patients exhibit a paucibacillary (PB) leprosy, of which the polar form is called tuberculoid. 4 At the other pole, there are patients classified as lepromatous leprosy, which is a multibacillary (MB) form. These patients show very low cellular immunity characterized by M. leprae-specific T-cell unresponsiveness and high bacterial load. 4 In this context, human leukocyte antigen (HLA) loci are crucial as antigen presentation is one of the pathways associated with cellular immune responses and differential levels of IFNg secreted, and, consequently, the outcome of the disease.
Genetic factors have a strong influence on the leprosytriggered immune response. 5, 6 Two recent genome scans have pinpointed chromosome 6p21 as a leprosy susceptibility locus. 7, 8 This region harbors the HLA gene cluster, which has been extensively studied for its role in leprosy pathogenesis. [9] [10] [11] [12] Candidate gene studies have detected association of leprosy with both class I and II genes. However, class II genes, especially the DRB1 locus, have been found more consistently associated with leprosy. 13 Several studies have reported association of HLA-DR2 (HLA-DR15 and DR16) with susceptibility to leprosy in India, Thailand and Brazil. [14] [15] [16] Rani et al. 17 confirmed these data by molecular typing, and reported association of DRB1*1501 with leprosy susceptibility, whereas DRB1*04 and DRB1*07 were associated with resistance to leprosy. In addition, HLA-DR3 has been found associated with leprosy susceptibility in Surinam and Mexico. 18, 19 Some of these studies had limited power owing to low numbers of individuals recruited. Moreover, to avoid premature conclusions, independent replication studies with different populations for confirmation of previous findings are necessary in multifactorial diseases, such as leprosy.
Thus, to understand better the contribution of the HLA-DRB1 locus to leprosy susceptibility we analyzed the distribution of DRB1 alleles in two ways: a casecontrol study in a large sample of Brazilian individuals searching for associations between alleles and the disease and a family based study with a Vietnamese population analyzing transmission of DRB1 alleles to leprosy affected children in simplex families, combining both aspects of adequate power and result replication.
Results
Distribution of HLA-DRB1* alleles and genotypes in a Brazilian population A total of 1269 Brazilian individuals (578 patients and 691 controls) were typed for HLA-DRB1. Table 1 shows the allelic frequency distributions in leprosy patients (MB and PB forms) and healthy controls along with the results of a log-linear model to identify alleles selectively enriched in either patients or controls. The DRB1*13 allele was chosen as the baseline for comparisons because it is the most frequent allele both in the overall study population and also among the controls. Frequencies for DRB1*15 and DRB1*10 showed a significant increase among leprosy patients. On the other hand, the frequencies of DRB1*04 and DRB1*07 and DRB1*12 were increased among healthy individuals. These results were significant, despite the low frequencies of DRB1*10 (0.02 and 0.04 for controls and cases, respectively) and DRB1*12 (0.02 and 0.01 for controls and cases, respectively) ( Table 1) . No statistically significant difference in the allele frequency distributions was observed between MB and PB forms ( Table 1) .
In a further step we looked at the genotypic distributions of HLA-DRB1, collapsing all the alleles that were not significantly different in a unique group -herein called NN, leaving the other five in separate groups, studying their combinations as genotypes (Table 2) . We also considered the intermarriage of the Brazilian population and investigated the ethnic-specific associations by stratifying the Brazilian population into Afro-and Euro-Brazilians ( Table 2 ). The comparison of genotypic frequencies in patients and controls demonstrated that the heterozygous individuals carrying DRB1*04 and DRB1*07 had a significant decreased chance of developing the disease ((OR) ¼ 0.61, Pvalue ¼ 0.008; OR ¼ 0.66, P-value ¼ 0.022, respectively). Heterozygotes carrying DRB1*10 and DRB1*15 had an increased chance of developing leprosy, even though the significance was borderline for both groups (OR ¼ 1.83, P-value ¼ 0.083; OR ¼ 1.41, P-value ¼ 0.04, respectively) ( Table 2 ). These results proved to be ethnic specific, as they are even stronger when data were stratified. For DRB1*04 and DRB1*07 the protection is stronger for Euro-Brazilians (OR ¼ 0.51, P-value ¼ 0.01; OR ¼ 0.53, P-value ¼ 0.01, respectively) whereas the risk is higher in Afro-Brazilians for both DRB1*10 and DRB1*15 (OR ¼ 3.21, P-value ¼ 0.024; OR ¼ 2.72, P-value ¼ 0.0002, respectively).
HLA-DRB1* alleles in Vietnamese leprosy patients
To reinforce the results found among Brazilians we analyzed the role of HLA-DRB1 alleles in Vietnamese leprosy simplex families (n ¼ 194) using a transmission disequilibrium test (TDT) design (Table 3 ). The associations observed in the Vietnamese families corroborated the results obtained for the Brazilian patients. The TDT analysis showed that the chance of transmission is lower for the DRB1*04 allele (OR ¼ 0.48, P-value ¼ 0.03) whereas higher for DRB1*10 (OR ¼ 2.03, P-value ¼ 0.04) ( Table 3) .
Discussion
Leprosy occurs in only a small percentage (1-3%) of infected people. 1 The risk of developing the disease depends on the ability to mount a protective cellular immune response against leprosy bacilli.
13 Table 1 Allele frequency distribution of HLA-DRB1* between leprosy patients vs controls and MB vs PB forms There is evidence that HLA polymorphisms modulate the cytokine profile of M. leprae-reactive CD4 þ T cells and hence influence the cellular-mediated immune response. The cytokine profile from leprosy patients and healthy controls with M. leprae-derived heat shock proteins (hsp65 and hsp18) showed the induction of a Th1 cytokine profile such as IFNg and IL-2 in the context of all HLA-DR restricted alleles, except HLA-DR1 and DR7, which induced a Th2 (IL-4) type response. 20 Indeed, the importance of HLA-DR was highlighted by Ottenhoff and coworkers, 12 showing that the majority of the restriction determinants for M. leprae reside in HLA-DR and not in DP or DQ molecules. 12 Thus, HLA-DR antigens play a major role in the presentation of M. leprae antigens to T cells in leprosy patients.
In this work we show that certain haplotypes in the HLA-DRB1 locus are associated with susceptibility to and protection from leprosy, but not with disease type of the disease. Moreover, the results clearly point to ethnicspecific associations, denoted by the differences we found among Euro-and Afro-Brazilians, and also in respect to the Vietnamese population. Our results corroborate the findings in other studies and the strength of our study is twofold: (i) we were able to work with a relatively large sample size for a genetic case-control study, which allowed us to detect small differences as well as to rule out nonexisting associations; (ii) we were able to replicate part of the results in a different population, using a different analytical approach -TDT in Vietnamese families.
Previous studies analyzing the HLA-DRB1 locus in leprosy patients have shown different haplotypes associated with susceptibility or resistance in distinct populations and most of them point to HLA-DR2, more specifically HLA-DRB1*15. 13 These studies have been conducted in very distinct populations such as Brazilians, 16 Indians 14 and Thais. 15 Furthermore, HLA-DRB1*10 is associated with susceptibility and HLA-DRB1*04 is associated with resistance to leprosy, both in the Brazilian and Vietnamese populations (Tables 2 and  3 ). On the other hand, when the clinical forms of the disease were analyzed no statistical differences were observed with respect to the allelic frequency distribution between MB and PB groups ( Table 1) , showing that HLA-DRB1 locus is associated only with susceptibility of leprosy per se and not with disease type.
Corroborating these previous data, our paper suggests that HLA-DRB1*15 is important among Brazilians, and points to an ethnic-specific effect as it is restricted to Afro-Brazilians, denoted by the increased ORs after stratification. Another interesting finding in this study is that HLA-DRB1*07 was also associated with leprosy resistance but only in Brazilians and the effect was restricted to Euro-Brazilians. The difference of HLA-DRB1*15 subtype distribution could be involved in an ethnic specificity of leprosy susceptibility. This is in accordance to the work of Moraes and coworkers, 21 where different trends of HLA-DRB1*15 subtypes in Brazilians were shown. The observed frequencies of DRB1*1503 were higher among Afro-and lower or absent among Euro-Brazilians and the reverse was observed for DRB1*1501. The ethnic-specific profiles are actually corroborated by other studies. For example, work analyzing the distribution of HLA class I and class II allele haplotypes among Venezuelan mestizos showed the genes of Mongoloid, Negroid and Caucasoid origin have created a distinctive HLA genetic profile in this mestizo population that influences HLA frequencies and, consequently, disease susceptibility. 22 Thus, although a clear ethnic specificity was observed when several alleles were compared, the association of HLA-DRB1*04 and DRB1*10 in Brazilian and Vietnamese individuals demonstrated that these alleles are major determinants of protective and susceptible cellular immune responses against M. leprae.
It is known that polymorphic residues in the binding cleft of HLA class II molecules control the binding of foreign peptides, and consequently, the immune response. For example, in HLA-DQB1 the presence of aspartic acid, instead of alanine, at codon 57 resulted in a significantly reduced ability to bind a peptide from the central region of the ESAT-6 protein and consequently less Ag-specific IFN-g production from CD4
þ -T cells in tuberculosis patients was observed. 23 In HLA-DR, codon differences that could account for distinct levels of IFNg and T-cell activation patterns are yet to be defined. On the basis of the results presented here, we could hypothesize that HLA-DRB1*04 would elicit a stronger cellular immune response, whereas HLA-DRB1*10 is involved with lower cellular immune levels. We would expect the same dichotomic pattern for HLA-DRB1*07 and HLA-DRB1*15, where the former induces higher and the latter lower levels of cellular immune response, but as the effect was observed only in Brazilians, the data suggest that the activation of immune responses through HLA is also dependent on other genes involved in specific pathways that could modulate the outcome of the disease.
In summary, infectious diseases are complex traits and besides HLA-DRB1, several other genes like IL-10, VDR and Parkin. 9, [24] [25] [26] [27] have been implicated in leprosy susceptibility, corroborated by result replication in more than one population. Thus, it is likely that genetic heterogeneity is a common feature of this disease, but other genes are also involved, as expected in any complex trait.
Materials and methods

Patients
A total of the 578 Brazilian leprosy patients from the Leprosy Out-Patient Unit, Oswaldo Cruz Foundation (FIOCRUZ, Rio de Janeiro, Brazil) were included in this study. The control group was constituted of 691 healthy donor subjects from the same geographic area of Rio de Janeiro. Three hundred and seventy-one MB and 207 PB patients were studied covering the entire clinical spectrum of the disease (polar and borderlines forms). All individuals were ascertained according to their ethnicity as African-Brazilians and Euro-Brazilians. Both groups were equally distributed among cases and controls (46.7 vs 43.4% for Afro-Brazilians, respectively, P-value ¼ 0.23). This study has been approved by the Ethical Committee within FIOCRUZ. We also enrolled a second independent set of 194 simplex families to perform the replication study using a family based design, where two parents and one leprosy-affected child were selected. The phenotype characterization and the clinical classification of these patients have been described previously. 27 Ethical approval of the study was obtained from the Local Health Authorities in Ho Chi Min City, Vietnam and the Ethics Committee of the McGill University Health Centre, Montreal, Canada. All patients were diagnosed on the basis of clinical and bacteriological criteria and classified according to the Ridley and Jopling scale. 2 DNA extraction and HLA-DRB1* typing For Brazilian samples genomic DNA was prepared from frozen whole blood by a commercially available DNAzol extraction kit (Invitrogen Life Technologies, Gaithersburg, MD, USA). HLA-DRB1 low-resolution typing was achieved after PCR amplification of exon 2 and reverse hybridization of the products by line probe assay (InnoLiPA -Innogenetics, Belgium).
For Vietnamese samples genomic DNA was extracted and typed according to methods described before. 27 The DRB1 alleles were identified using sequence-specific primers (SSP) for PCR amplification as described previously. 28 
Statistical analysis
In Brazilians, log-linear and logistic regression models were used to test the association between alleles and genotypes, respectively, and leprosy. Gender and ethnicity were also used as covariables in our models, being the latter used to stratify our analyses as well. All the analyses for the Brazilian sample were carried out with R for Windows 2.1.1. 29 In the Vietnamese sample, a family-based association analysis was performed using the classical TDT as implemented in the software FBAT. 30 For the gene under study (DRB1) the transmission of each allele was compared to the transmission of all the others combined. P-values were computed using the empirical variance-covariance estimator, 31 and tests were performed assuming either an additive or a dominant model. Alleles showing some evidence of association were also analyzed using conditional logistic regression to estimate odds-ratio. 32 Conditional logistic analysis was performed using the PHREG procedure as implemented in the SAS software v.8.1 (SAS institute, Cary, NC, USA).
This study has adequate power to study the distribution of HLA alleles. Given that the distribution of alleles is multinomial, a power analysis via 10 000 simulations of the observed frequencies, considering the distribution of cases as the true alternative hypothesis, yielded the following results: a: 0.1; power: 92.61%; a: 0.05; power:
86.97%; a: 0.01; power: 69.48%. Sample size calculation ahead of time is a very important step of any study design. In our case, for a significance level of 0.05 (which is the one used in this study), given the distributions found in our samples we get 86.97% power, which is perfectly adequate for our purposes.
